Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vaccine Effectiveness × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 126 Ovarian Neoplasms 102 Endometrial Neoplasms 79 Uterine Cervical Dysplasia 16 Papillomavirus Infections 15 Breast Neoplasms 15 Neoplasms 13 Carcinoma, Ovarian Epithelial 13 Fallopian Tube Neoplasms 12 Vulvar Neoplasms 10 Colorectal Neoplasms 10 Recurrence 9 Stomach Neoplasms 8 Prostatic Neoplasms 8 Neoplasm Metastasis 8 Endometrial Hyperplasia 8 Carcinoma, Non-Small-Cell Lung 8 Squamous Intraepithelial Lesions 7 Acquired Immunodeficiency Syndrome 7 Pancreatic Neoplasms 6 Cervical Cancer Screening 6 Anus Neoplasms 6 Vaginal Neoplasms 5 Uterine Neoplasms 5 Pelvic Neoplasms 5 Obesity 5 Locally Advanced Cervical Cancer 5 Head and Neck Neoplasms 5 Sarcoma 4 Rectal Neoplasms 4

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡